Açıklama

Subgroup analysis by curcumin formulation in the ulcerative colitis meta-analysis explores whether bioavailability-enhanced preparations yield superior outcomes compared to standard curcumin.

Figure 9

Forest Plot

Source Paper

Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Nutrients (2018)

PMID: 30424514

DOI: 10.3390/nu10111737

Cite This Figure

![Figure 9: Subgroup analysis by curcumin formulation in the ulcerative colitis meta-analysis explores whether bioavailability-enhanced preparations yield superior outcomes compared to standard curcumin.]()

> Source: Maria G Grammatikopoulou et al. "Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Co." *Nutrients*, 2018. PMID: [30424514](https://pubmed.ncbi.nlm.nih.gov/30424514/)

<figure>
  <img src="" alt="Subgroup analysis by curcumin formulation in the ulcerative colitis meta-analysis explores whether bioavailability-enhanced preparations yield superior outcomes compared to standard curcumin." />
  <figcaption>Figure 9. Subgroup analysis by curcumin formulation in the ulcerative colitis meta-analysis explores whether bioavailability-enhanced preparations yield superior outcomes compared to standard curcumin.<br>  Source: Maria G Grammatikopoulou et al. "Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Co." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30424514/">30424514</a></figcaption>
</figure>

İlgili Kanıtlar

Curcumin için Ulcerative Colitis (UC)

Derece B · 5 çalışma